Spain Cell Reprogramming Market Size & Outlook, 2023-2030

The cell reprogramming market in Spain is expected to reach a projected revenue of US$ 19.2 million by 2030. A compound annual growth rate of 7.9% is expected of Spain cell reprogramming market from 2024 to 2030.
Revenue, 2023 (US$M)
$11.3
Forecast, 2030 (US$M)
$19.2
CAGR, 2024 - 2030
7.9%
Report Coverage
Spain

Spain cell reprogramming market highlights

  • The Spain cell reprogramming market generated a revenue of USD 11.3 million in 2023 and is expected to reach USD 19.2 million by 2030.
  • The Spain market is expected to grow at a CAGR of 7.9% from 2024 to 2030.
  • In terms of segment, mrna reprogramming was the largest revenue generating technology in 2023.
  • MRNA Reprogramming is the most lucrative technology segment registering the fastest growth during the forecast period.


Cell reprogramming market data book summary

Market revenue in 2023USD 11.3 million
Market revenue in 2030USD 19.2 million
Growth rate7.9% (CAGR from 2023 to 2030)
Largest segmentMrna reprogramming
Fastest growing segmentMRNA Reprogramming
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSendai Virus-based Reprogramming, MRNA Reprogramming, Episomal Reprogramming
Key market players worldwideThermo Fisher Scientific Inc, Merck KGaA, Bio-Techne Corp, ReproCELL, Lonza Group Ltd, FUJIFILM Holdings Corp, Astellas Pharma Inc, Allele Biotech, Alstem, STEMCELL Technologies


Other key industry trends

  • In terms of revenue, Spain accounted for 3.0% of the global cell reprogramming market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK cell reprogramming market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 41.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cell Reprogramming Market Companies

Name Profile # Employees HQ Website

Spain cell reprogramming market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell reprogramming market will help companies and investors design strategic landscapes.


Mrna reprogramming was the largest segment with a revenue share of 33.63% in 2023. Horizon Databook has segmented the Spain cell reprogramming market based on sendai virus-based reprogramming, mrna reprogramming, episomal reprogramming covering the revenue growth of each sub-segment from 2018 to 2030.


The strong presence of well-established and emerging product manufacturers and the continuous organic & inorganic growth strategies being implemented by them are expected to create a lucrative environment for market growth.

For instance, in April 2022, researchers at IRB Barcelona noted signs of rejuvenation in the pancreas, spleen, liver, and blood of mice following a single cycle of cell reprogramming. The team accomplished this by examining rejuvenation indicators, including molecular markers in DNA, gene expression, and cell metabolism.

Reasons to subscribe to Spain cell reprogramming market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Spain cell reprogramming market databook

  • Our clientele includes a mix of cell reprogramming market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Spain cell reprogramming market , including forecasts for subscribers. This country databook contains high-level insights into Spain cell reprogramming market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Spain cell reprogramming market size, by technology, 2018-2030 (US$M)

Spain Cell Reprogramming Market Outlook Share, 2023 & 2030 (US$M)

Spain cell reprogramming market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more